Minimum Investment
₹124,800
Price Range
₹196 to ₹208
Lot Size
600 shares
Issue Size
₹30 Cr
About the Company
Incorporated in June 2024, Avience Biomedicals Limited is an ISO certified company specializing in manufacturing, supplying, and exporting molecular diagnostic solutions, focusing on biotechnology, genomics, and the IVD industry.
Bookbuilding IPO
IPO Objectives
- Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh
- Funding the working capital requirements of the Company
- General Corporate Purposes
Important Dates
| Bid/Offer Opens On | 18-06-2026 |
| Bid/Offer Closes On | 22-06-2026 |
| Finalisation of Basis of Allotment | 23-06-2026 |
| Initiation of Refunds | 24-06-2026 |
| Credit of Shares to Demat | 24-06-2026 |
| IPO Listing Date | 25-06-2026 |
IPO Subscription Status
| Category | Offered Shares | Applied Shares | Times |
|---|---|---|---|
| QIB | 273,600 | 53,837,400 | 196.77x |
| NII | 207,000 | 123,709,800 | 597.63x |
| NII ( >10 lakh) | 138,000 | 92,566,800 | 670.77x |
| NII ( <10 lakh) | 69,000 | 31,143,000 | 451.35x |
| Retail | 481,200 | 0 | 0.00x |
| Total | 961,800 | 177,547,200 | 184.60x |
Grey Market Premium (GMP)
₹134.00
per share
Registrar
Skyline Financial Services Pvt.Ltd.
Lead Managers
- Fintellectual Corporate Advisors Pvt.Ltd.
Company Promoters
- Mr. Dharam Deo Choudhary
- Mr. Ram Nagina Choudhary
- Mr. Janardan Pal and Ms. Deepa Choudhary.\r\n
